CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 8-K Event Executive or director change
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,085 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 962 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,559 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Strategy & Transformation gave up 958 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,435 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · New debt or obligation · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award Director acquired 49,796 shares (grant or award)
Page 6 of 104 · 2,077 filings